Diabetic Ketoacidosis and Acute Pancreatitis: Serious Adverse Effects of Everolimus

Ann Emerg Med. 2017 May;69(5):666-667. doi: 10.1016/j.annemergmed.2017.01.002.

Authors

Gyanendra Kumar Acharya¹, Angel Guido Hita¹, Sai-Ching J Yeung¹, Sai-Ching J Yeung²

Affiliations

¹ Department of Emergency Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
² Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

PMID: 28442095
DOI: 10.1016/j.annemergmed.2017.01.002

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acute Disease
Antineoplastic Agents / adverse effects*
Breast Neoplasms / drug therapy*
Diabetic Ketoacidosis / chemically induced*
Everolimus / adverse effects*
Female
Humans
Hypertriglyceridemia / chemically induced
Middle Aged
Neoplasm Metastasis
Pancreatitis / chemically induced*

Substances

Antineoplastic Agents
Everolimus